Condensed Statement of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses
Research and development	$ 12,402	$ 7,861	$ 23,526	$ 13,221
General and administrative	4,089	2,599	7,791	4,096
Total operating expenses	16,491	10,460	31,317	17,317
Loss from operations	(16,491)	(10,460)	(31,317)	(17,317)
Other income
Interest income	424	107	590	149
Total other income	424	107	590	149
Net loss	(16,067)	(10,353)	(30,727)	(17,168)
Other comprehensive loss:
Unrealized loss on available-for-sale securities	(404)	21	(1,822)	(33)
Total comprehensive loss	$ (16,471)	$ (10,332)	$ (32,549)	$ (17,201)
Net loss per share, basic (in dollars per share)	$ (0.32)	$ (0.21)	$ (0.62)	$ (0.67)
Net loss per share, diluted (in dollars per share)	$ (0.32)	$ (0.21)	$ (0.62)	$ (0.67)
Weighted-average shares outstanding, basic	49,622,752	49,258,449	49,583,886	25,540,922
Weighted-average shares outstanding, diluted	49,622,752	49,258,449	49,583,886	25,540,922